Christine Ocampo, Vice President, Finance at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 55,000 shares at $9.45 ($520K) on 2014-09-15, disclosed to the SEC on 2014-09-17.
Scheduled sale ($520k) by Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AVNR | SELL | 2014-10-24 | $25K | — | Filing → |
| AVNR | SELL | 2014-08-28 | $13K | — | Filing → |
| AVNR | SELL | 2014-05-16 | $189K | — | Filing → |